The Clinical Trial Imaging Services Market Size is valued at 1155.6 Million in 2022 and is predicted to reach 1901.2 Million by the year 2031 at a 5.8 % CAGR during the forecast period for 2023-2031.
Clinical Trial is a protocol that studies new treatments and tests and checks their effects on human health. Clinical trials are used to treat cardiovascular diseases, cancer therapies, and many other health conditions. It is also an important part of the drug development process. The imaging technique is a key factor in clinical trials. The clinical trial imaging technique offers data accuracy, adaptability, consistency, and compliance to clinical studies. The global clinical trial imaging services market has been rising due to the advanced medical technologies, development, and new software launch.
The factors such as increasing use of clinical trial imaging devices, adoption of advanced medical technologies, rising government investments for research and development of imaging services are expected to boost the market's growth over the forecast period. Furthermore, increased healthcare expenditure and the rising prevalence of human health diseases are fueling the growth of the clinical trial imaging services market. The high cost of clinical imaging service with advanced technologies and poor reimbursement policies can downscale the market growth during the Forecast period 2022-2030.
The Global clinical trial imaging services market is segmented into Service Types, Therapeutic areas, End-users, and regions. The Service Types segment is further bifurcated into Clinical Trial Design & Consultation Services, Reading &, Operational Imaging Services, Project & Data Management Services, and Other Service Types. Operational Imaging Services and Project & Data Management Services and are the main drivers of this market. In terms of Therapeutic areas, the market can be divided into Oncology, Neurology, Endocrinology, Analytical Services Cardiology, Gastroenterology, and Other Therapeutic Area. Oncology is the fastest-growing clinical trial imaging market segment due to the increasing prevalence of cancer, leading to growth in novel clinical trial imaging techniques.
Furthermore, the neurology segment is anticipated to boost the market, owing to the rise in the use of imaging in neurology clinical trials. By End-users, the market is segmented into Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, and Academic & Government Research Institutes. Pharmaceutical & Biotechnology Companies hold the largest share of this market. Based on the region, the clinical trial imaging services market is divided into North Pharmaceutical & Biotechnology Companies America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America dominated the global clinical trial imaging services market and will continue this trend over the forecast period, owing to ising adoption of advanced medical technologies, the increasing number of pharmaceutical companies, rand high clinical R&D investments by the government.
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 1155.6 Million |
|
Revenue Forecast In 2031 |
USD 1901.2 Million |
|
Growth Rate CAGR |
CAGR of 5.8 % from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Service Types, By Therapeutic Area, By End-Users |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Biospective Inc., Calyx, Bioclinica Inc., Ert Clinical, Proscan Imaging, Ixico Plc, Intrinsic Imaging, Llc, Imaging Endpoints, Micron, Inc., Icon Plc., Medpace, Inc., Median Technologies, Pharmtrace, and Others |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Clinical Trial Imaging Services Market Snapshot
Chapter 4. Global Clinical Trial Imaging Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Service Types, Estimates & Trend Analysis
5.1. By Service Types, & Market Share, 2019 & 2030
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following By Service Types:
5.2.1. Clinical Trial Design & Consultation Services
5.2.2. Reading & Analytical Services
5.2.3. Operational Imaging Services
5.2.4. Project & Data Management Services
5.2.5. Other Service Types
Chapter 6. Market Segmentation 1: By Therapeutic Area Estimates & Trend Analysis
6.1. By Therapeutic Area & Market Share, 2019 & 2030
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following By Therapeutic Area:
6.2.1. Oncology
6.2.2. Neurology
6.2.3. Endocrinology
6.2.4. Cardiology
6.2.5. Gastroenterology
6.2.6. Other Therapeutic Area
Chapter 7. Market Segmentation 1: By End-Users Estimates & Trend Analysis
7.1. By End-Users & Market Share, 2019 & 2030
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following By End-Users:
7.2.1. Pharmaceutical & Biotechnology Companies
7.2.2. Medical Device Manufacturers
7.2.3. Academic & Government Research Institutes
Chapter 8. Clinical Trial Imaging Services Market Segmentation 3: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Clinical Trial Imaging Services Market revenue (US$ Million) estimates and forecasts By Service Types, 2019 - 2030
8.1.2. North America Clinical Trial Imaging Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2019 - 2030
8.1.3. North America Clinical Trial Imaging Services Market revenue (US$ Million) estimates and forecasts By End-Users, 2019 - 2030
8.1.4. North America Clinical Trial Imaging Services Market revenue (US$ Million) estimates and forecasts by country, 2019 - 2030
8.2. Europe
8.2.1. Europe Clinical Trial Imaging Services Market revenue (US$ Million) By Service Types, 2019 - 2030
8.2.2. Europe Clinical Trial Imaging Services Market revenue (US$ Million) By Therapeutic Area, 2019 - 2030
8.2.3. Europe Clinical Trial Imaging Services Market revenue (US$ Million) By End-Users, 2019 - 2030
8.2.4. Europe Clinical Trial Imaging Services Market revenue (US$ Million) by country, 2019 - 2030
8.3. Asia Pacific
8.3.1. Asia Pacific Clinical Trial Imaging Services Market revenue (US$ Million) By Service Types, 2019 - 2030
8.3.2. Asia Pacific Clinical Trial Imaging Services Market revenue (US$ Million) By Therapeutic Area, 2019 - 2030
8.3.3. Asia Pacific Clinical Trial Imaging Services Market revenue (US$ Million) By End-Users, 2019 - 2030
8.3.4. Asia Pacific Clinical Trial Imaging Services Market revenue (US$ Million) by country, 2019 - 2030
8.4. Latin America
8.4.1. Latin America Clinical Trial Imaging Services Market revenue (US$ Million) By Service Types, (US$ Million)
8.4.2. Latin America Clinical Trial Imaging Services Market revenue (US$ Million) By Therapeutic Area, (US$ Million)
8.4.3. Latin America Clinical Trial Imaging Services Market revenue (US$ Million) By End-Users, (US$ Million)
8.4.4. Latin America Clinical Trial Imaging Services Market revenue (US$ Million) by country, (US$ Million) 2019 - 2030
8.5. Middle East & Africa
8.5.1. Middle East & Africa Clinical Trial Imaging Services Market revenue (US$ Million) By Service Types, (US$ Million)
8.5.2. Middle East & Africa Clinical Trial Imaging Services Market revenue (US$ Million) By Therapeutic Area, (US$ Million)
8.5.3. Middle East & Africa Clinical Trial Imaging Services Market revenue (US$ Million) By End-Users, (US$ Million)
8.5.4. Middle East & Africa Clinical Trial Imaging Services Market revenue (US$ Million) by country, (US$ Million) 2019 - 2030
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Bioclinica Inc.
9.2.2. Biospective Inc.
9.2.3. Calyx
9.2.4. Ert Clinical
9.2.5. Icon Plc.
9.2.6. Ixico Plc
9.2.7. Intrinsic Imaging, Llc
9.2.8. Imaging Endpoints
9.2.9. Micron, Inc.
9.2.10. Median Technologies
9.2.11. Medpace, Inc.
9.2.12. Pharmtrace
9.2.13. Proscan Imaging
9.2.14. Other Prominent Player
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 based on Service Types
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 based on Therapeutic Area
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 based on End-Users
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 based on Region
North America clinical trial imaging services market revenue (US$ Million) by Country, 2019 to 2030
Europe clinical trial imaging services market revenue (US$ Million) by Country, 2019 to 2030
Asia Pacific clinical trial imaging services market revenue (US$ Million) by Country, 2019 to 2030
Latin America clinical trial imaging services market revenue (US$ Million) by Country, 2019 to 2030
Middle East & Africa clinical trial imaging services market revenue (US$ Million) by Country, 2019 to 2030
Competitive Landscape
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
